Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 270

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 2
Chunk 270
---
     -  
     -  
     1,205  
     -  
     1,205 
  
    Shares issued in consideration pursuant to consulting agreement 
     350,000  
     -  
     676  
     -  
     676 
  
    Shares issued in consideration pursuant to Virion Contribution Agreement 
     750,000  
     -  
     1,272  
     -  
     1,272 
  
    Offering costs 
     -  
     -  
     (2,049) 
     -  
     (2,049)
  
    Issuance of warrants 
     -  
     -  
     2,301  
     -  
     2,301 
  
    Shares Issued for conversion of a portion of the outstanding principal due under the 2023 Convertible Note 
     5,005  
     -  
     7  
     -  
     7 
  
    Balances at December 31, 2023 
     35,249,046  
    $-  
    $105,292  
    $(196,055) 
    $(90,763)
  
    Balance  
     35,249,046  
    $-  
    $105,292  
    $(196,055) 
    $(90,763)

    Net loss 
     -  
     -  
     -  
     (9,480) 
     (9,480)
  
    Stock based compensation 
     -  
     -  
     745  
     -  
     745 
  
    Issuance of common stock 
     169,582  
     -  
     1,795  
     -  
     1,795 
  
    Shares issued to vendors 
     50,000  
     -  
     87  
     -  
     87 
  
    Balances at December 31, 2024 
     35,468,628  
    $-  
    $107,919  
    $(205,535) 
    $(97,616)

    Balances 
     35,468,628